AKTIEN IM FOKUS 2: FMC und Fresenius verlieren zweistellig - Novo-Studienerfolg -October 11, 2023 at 04:17 am EDT

A research success by diabetes specialist Novo Nordisk dealt a heavy blow to the shares of dialysis providers on Wednesday. Shares of Fresenius Medical Care slumped by almost a quarter at their peak...

Related Keywords

United States ,David Adlington ,Graham Doyle ,Novo Nordisk ,Fresenius ,Fresenius Medical Care ,Markets ,